An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC
Public ClinicalTrials.gov record NCT04155190. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double Blind, Vehicle-controlled, Phase 2 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Patients With Non-Gorlin High Frequency BCC
Study identification
- NCT ID
- NCT04155190
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Sol-Gel Technologies, Ltd.
- Industry
- Enrollment
- 47 participants
Conditions and interventions
Conditions
Interventions
- Patidegib Topical Gel, 2% Drug
- Patidegib Topical Gel, Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 19, 2019
- Primary completion
- Apr 22, 2021
- Completion
- Apr 22, 2021
- Last update posted
- May 30, 2023
2019 – 2021
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Axiom Research, LLC | Apple Valley | California | 92307 | — |
| Axiom Research, LLC | Colton | California | 92324 | — |
| Center for Dermatology Clinical Research, Inc. | Fremont | California | 94538 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| The Dermatology Center of Newport | Newport Beach | California | 92660 | — |
| Palm Beach Dermatology Research | Delray Beach | Florida | 33484 | — |
| Leavitt Medical Associates of Florida | Ormond Beach | Florida | 32174 | — |
| PellePharm Investigative Site | Saint Augustine | Florida | 32080 | — |
| The Indiana Clinical Trials Center | Plainfield | Indiana | 46168 | — |
| Grekin Skin Institute | Warren | Michigan | 48088 | — |
| PellePharm Investigative Site | Henderson | Nevada | 89052 | — |
| Skin Laser and Surgery Specialists of NY&NJ | Hackensack | New Jersey | 07601 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| University of Utah | Murray | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04155190, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 30, 2023 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04155190 live on ClinicalTrials.gov.